Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

quality care products llc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bryant ranch prepack - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period a

Australija - engleski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atovaquone, quantity: 150 mg/ml - oral liquid, suspension - excipient ingredients: poloxamer; saccharin sodium; benzyl alcohol; purified water; xanthan gum; flavour - wellvone suspension is indicated for: acute treatment of mild to moderate pneumocystis carinii pneumonia (pcp) (difference of alveolar and arterial oxygen tensions [(a-a)do2]<=45mmhg(6kpa) and oxygen tension in arterial blood (pa02)>=60mmhg(8kpa) breathing room air) in adult patients with aids who are intolerant of trimethoprim/sulphamethoxazole therapy.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

well herb pty ltd - commiphora myrrha,dictamnus desycarpus,gleditsia sinensis,poterium officinale,rheum palmatum,sophora flavescens -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

well herb pty ltd - angelica dahurica,areca catechu,atractylodes lancea,citrus reticulata,glycyrrhiza uralensis,magnolia officinalis,perilla frutescens,pinellia ternata,pogostemon cablin,wolfiporia cocos -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

well herb pty ltd - angelica dahurica, quantity: 13.986 mg/ml (equivalent: angelica dahurica, qty 120 mg/ml); wolfiporia cocos, quantity: 13.986 mg/ml (equivalent: wolfiporia cocos, qty 120 mg/ml); citrus aurantium, quantity: 13.986 mg/ml (equivalent: citrus aurantium, qty 120 mg/ml; equivalent: oxedrine, qty 30 microgram/ml); atractylodes lancea, quantity: 9.324 mg/ml (equivalent: atractylodes lancea, qty 80 mg/ml); citrus reticulata, quantity: 9.324 mg/ml (equivalent: citrus reticulata, qty 80 mg/ml; equivalent: oxedrine, qty 51 microgram/ml); magnolia officinalis, quantity: 9.324 mg/ml (equivalent: magnolia officinalis, qty 80 mg/ml); pinellia ternata, quantity: 9.324 mg/ml (equivalent: pinellia ternata, qty 80 mg/ml); glycyrrhiza uralensis, quantity: 10 mg/ml (equivalent: glycyrrhiza uralensis, qty 30 mg/ml); pogostemon cablin, quantity: 800 microgram/ml; perilla frutescens, quantity: 40 microgram/ml - oral liquid - excipient ingredients: polysorbate 80; purified water - traditionally used in chinese medicine to clear/dry/drain/eliminate/resolve dampness ; traditionally used in chinese medicine to soothe/descend the arisen stomach-qi ; traditionally used in chinese medicine to clear/expel wind-cold-dampness ; decrease/reduce/relieve diarrhoea ; traditionally used in chinese medicine to decrease/reduce/relieve diarrhoea ; traditionally used in chinese medicine to helps decrease/reduce/relieve symptoms of traveller's diarrhoea ; helps decrease/reduce/relieve symptoms of traveller's diarrhoea ; traditionally used in chinese medicine to harmonise/soothe the stomach ; traditionally used in chinese medicine to antiemetic/decrease/reduce/relieve vomiting ; antiemetic/decrease/reduce/relieve vomiting

Australija - engleski - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - oxygen, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australija - engleski - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - oxygen, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - ? hypoxia of any cause. ? as diluent for gaseous and volatile anaesthetic agents.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see  error! hyperlink reference not valid. and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see  warnings  and  dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated du

Australija - engleski - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - air, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)